Cutera, Inc.

Total revenue for Q3 2024 was $32.5 million, down from $46.5 million in Q3 2023. Excluding $7.1 million of skin care revenue in the prior-year period, revenue declined by $6.8 million year over year, mainly due to lower North American capital equipment and consumables sales. Non-GAAP gross profit was $3.7 million, with gross margin of 11.5% versus 19.3% a year ago; the decline was driven primarily by a $10.1 million excess and obsolete inventory charge, which management said represented 31 percentage points of gross margin. Non-GAAP operating expenses were $34.7 million versus $39.8 million last year, including $5.4 million of bad debt expense. Cash, cash equivalents and restricted cash ended the quarter at $59.0 million, down from $84.3 million at June 2024. Management reaffirmed full-year revenue guidance of $140 million to $145 million and expects year-end cash, cash equivalents and restricted cash of approximately $40 million.

Taylor Harris emphasized that the company is still operating in a difficult capital-spending environment, but said Cutera remains on track with the plans laid out last quarter. He highlighted progress in operational execution, especially field service, where North American 72-hour response performance improved to 90% to 100% in recent weeks and months. His tone was constructive but cautious: he repeatedly pointed to stronger international AviClear utilization, a more productive North America sales force, and the expectation that 2025 will benefit from both operating improvements and inventory conversion to cash.

Stuart Drummond focused on the quarter’s reported numbers and the balance sheet. He said Q3 revenue was $32.5 million, non-GAAP gross profit was $3.7 million with an 11.5% gross margin, and operating expenses were $34.7 million, including $5.4 million of bad debt expense. He also noted the quarter-end cash, cash equivalents and restricted cash balance of $59.0 million and reaffirmed full-year revenue guidance of $140 million to $145 million, with year-end cash expected at about $40 million. Management also reiterated that inventory reserves may continue, but should be significantly lower than recent quarters.

Analysts pressed on North America sales force changes, gross margin recovery, the $10.1 million inventory charge, AviClear returns, and the path to growth in 2025. Management said the North America commercial team is now more productive, with fewer reps but better contribution broadening across the team, and that underlying gross margin in the low 40%s should improve with more volume, better mix, AviClear consumables, and efficiency gains. On AviClear returns, management said the installed base peaked at about 1,250 leased systems, was down to 785 at quarter-end, and that roughly 200 more are already on a return list; they are now concentrating on about 150 committed accounts to drive utilization. Taylor Harris also said 2025 growth could come from continued international expansion and improved North America productivity, while acknowledging the macro environment has not improved.